Toyama Of Japan Earmarks $11 Million To Launch Flu Drug Facility
This article was originally published in PharmAsia News
Executive Summary
Japan's Toyama Chemical, a unit of Fujifilm Holdings, said it plans to spend about $11 million at its main plant to launch a new flu drug in early 2011